RCM Technologies Inc Dossier
|
SectorIndustrials IndustryHuman Resource & Employment Services Beta (adjusted)0.51 Intrinsic Value $46.36median of 6 methods · middle span $22-$358based on filings through 4 Jul 2026 Market Price $42.02Price as of 1 Oct 2026 Near fair valueIntrinsic value is 10% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $298.8M Enterprise Value $316.9M Shares Outstanding 7.3M diluted Moat Rating Wide Next Earnings Date4 Nov 2026 Last ex-dividend21 Dec 2017 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary RCM Technologies (RCMT) is a highly specialized provider of business and technology solutions across three key segments: Specialty Healthcare, Engineering, and Life Sciences. The company is experiencing strong secular tailwinds, particularly in its Engineering division, which boasts a record backlog of over $70 million for fiscal 2026 driven by clean energy, grid modernization, and aerospace demand. While the Specialty Healthcare segment continues to deliver stable, high-margin revenue through school-based contracts, short-term headwinds such as elevated excess medical costs and temporary engineering project transitions require monitoring. Overall, RCMT's aggressive share buybacks and robust backlog support a strong valuation upside. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$36.00 Mean target$38.00 High · most bullish analyst$40.00 Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $24.0010% Delays in engineering project execution lead to backlog stagnation, and the Specialty Healthcare segment faces margin compression from rising labor costs and persistent excess medical expenses. Failure to remediate material weaknesses in internal controls damages investor sentiment. Base CaseCentral scenario $36.0060% Steady execution of the $70 million engineering backlog offsets near-term segment softness. Specialty Healthcare remains the primary revenue driver with stable school district demand. Share repurchases continue to support EPS growth, and the company maintains its trajectory toward its consensus price target. Bull CaseUpside scenario $36.0030% The record $70 million engineering backlog converts rapidly into high-margin revenue, while school-based healthcare contracts expand faster than expected. Remediation of internal control weaknesses is completed ahead of schedule, and excess medical costs subside, driving adjusted EBITDA margins above 11%. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |